CANY
AVEO

Caxton Associates (New York)’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Caxton Associates (New York)’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-117,452
Closed -$1.76M – 669
2022
Q4 		$1.76M Buy
117,452
+3,291
+3% +$49.2K 0.12% 42
2022
Q3 		$940K Buy
+114,161
New +$940K 0.13% 118